A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation

Background: Osteoprotegerin (OPG), as an osteoclast antagonist, limits mineralised tissue resorption under physiological conditions. Previous work investigating OPG in a rat periodontal ligament (PDL) ankylosis model found no inhibitory effect on osteoclasts when OPG was administered at a dosage of...

Full description

Bibliographic Details
Main Authors: Curl Linda, Barker Christopher, Dreyer Craig, Sampson Wayne
Format: Article
Language:English
Published: Sciendo 2012-11-01
Series:Australasian Orthodontic Journal
Online Access:https://doi.org/10.2478/aoj-2012-0020
_version_ 1797752404883537920
author Curl Linda
Barker Christopher
Dreyer Craig
Sampson Wayne
author_facet Curl Linda
Barker Christopher
Dreyer Craig
Sampson Wayne
author_sort Curl Linda
collection DOAJ
description Background: Osteoprotegerin (OPG), as an osteoclast antagonist, limits mineralised tissue resorption under physiological conditions. Previous work investigating OPG in a rat periodontal ligament (PDL) ankylosis model found no inhibitory effect on osteoclasts when OPG was administered at a dosage of 2.5mg/kg.1,2
first_indexed 2024-03-12T17:03:54Z
format Article
id doaj.art-55fd8e8e29b34d51914be4885961844e
institution Directory Open Access Journal
issn 2207-7480
language English
last_indexed 2024-03-12T17:03:54Z
publishDate 2012-11-01
publisher Sciendo
record_format Article
series Australasian Orthodontic Journal
spelling doaj.art-55fd8e8e29b34d51914be4885961844e2023-08-07T06:57:55ZengSciendoAustralasian Orthodontic Journal2207-74802012-11-0128221922410.2478/aoj-2012-0020A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammationCurl Linda0Barker Christopher1Dreyer Craig2Sampson Wayne31Orthodontic Unit, School of Dentistry, The University of Adelaide, Adelaide, South Australia, Australia1Orthodontic Unit, School of Dentistry, The University of Adelaide, Adelaide, South Australia, Australia1Orthodontic Unit, School of Dentistry, The University of Adelaide, Adelaide, South Australia, Australia1Orthodontic Unit, School of Dentistry, The University of Adelaide, Adelaide, South Australia, AustraliaBackground: Osteoprotegerin (OPG), as an osteoclast antagonist, limits mineralised tissue resorption under physiological conditions. Previous work investigating OPG in a rat periodontal ligament (PDL) ankylosis model found no inhibitory effect on osteoclasts when OPG was administered at a dosage of 2.5mg/kg.1,2https://doi.org/10.2478/aoj-2012-0020
spellingShingle Curl Linda
Barker Christopher
Dreyer Craig
Sampson Wayne
A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
Australasian Orthodontic Journal
title A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
title_full A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
title_fullStr A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
title_full_unstemmed A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
title_short A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
title_sort pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation
url https://doi.org/10.2478/aoj-2012-0020
work_keys_str_mv AT curllinda apharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT barkerchristopher apharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT dreyercraig apharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT sampsonwayne apharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT curllinda pharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT barkerchristopher pharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT dreyercraig pharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation
AT sampsonwayne pharmacodynamicinvestigationintotheefficacyofosteoprotegerinduringasepticinflammation